Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 38% ± 8% | |
| glutamatergic neuron | 3 studies | 40% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 93% | 1779.98 | 2462 / 2642 | 49% | 1.62 | 344 / 705 |
| adrenal gland | 7% | 24.01 | 19 / 258 | 53% | 2.11 | 121 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 2.21 | 12 / 29 |
| ovary | 1% | 1.22 | 1 / 180 | 10% | 0.20 | 44 / 430 |
| breast | 4% | 12.27 | 19 / 459 | 2% | 0.05 | 21 / 1118 |
| lung | 0% | 0 | 0 / 578 | 5% | 0.11 | 57 / 1155 |
| esophagus | 1% | 3.33 | 13 / 1445 | 4% | 0.05 | 7 / 183 |
| adipose | 3% | 16.01 | 40 / 1204 | 0% | 0 | 0 / 0 |
| uterus | 1% | 2.77 | 2 / 170 | 2% | 0.04 | 9 / 459 |
| stomach | 0% | 0 | 0 / 359 | 3% | 0.06 | 8 / 286 |
| bladder | 0% | 0 | 0 / 21 | 3% | 0.18 | 14 / 504 |
| prostate | 0% | 0.72 | 1 / 245 | 2% | 0.04 | 11 / 502 |
| pancreas | 0% | 0 | 0 / 328 | 2% | 0.05 | 4 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
| kidney | 0% | 0 | 0 / 89 | 2% | 0.07 | 18 / 901 |
| blood vessel | 2% | 4.97 | 24 / 1335 | 0% | 0 | 0 / 0 |
| skin | 0% | 0.81 | 8 / 1809 | 1% | 0.04 | 6 / 472 |
| intestine | 1% | 2.23 | 6 / 966 | 1% | 0.04 | 4 / 527 |
| thymus | 0% | 0.66 | 2 / 653 | 1% | 0.01 | 5 / 605 |
| liver | 0% | 0 | 0 / 226 | 1% | 0.02 | 3 / 406 |
| heart | 1% | 1.24 | 6 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.46 | 1 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.17 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030322 | Biological process | stabilization of membrane potential |
| GO_0071805 | Biological process | potassium ion transmembrane transport |
| GO_0034702 | Cellular component | monoatomic ion channel complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0022841 | Molecular function | potassium ion leak channel activity |
| GO_0015271 | Molecular function | outward rectifier potassium channel activity |
| Gene name | KCNK12 |
| Protein name | Potassium channel subfamily K member 12 (Tandem pore domain halothane-inhibited potassium channel 2) (THIK-2) |
| Synonyms | |
| Description | FUNCTION: Probable potassium channel subunit. No channel activity observed in heterologous systems. May need to associate with another protein to form a functional channel (By similarity). . |
| Accessions | Q9HB15 ENST00000327876.5 |